Greene KL - Search Results

1

Impact of ⁶⁸Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.

Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR. Hope TA, et al. Among authors: greene kl. J Nucl Med. 2017 Dec;58(12):1956-1961. doi: 10.2967/jnumed.117.192476. Epub 2017 May 18. J Nucl Med. 2017. PMID: 28522741 Free article.

2

Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).

Greene KL, Meng MV, Elkin EP, Cooperberg MR, Pasta DJ, Kattan MW, Wallace K, Carroll PR. Greene KL, et al. J Urol. 2004 Jun;171(6 Pt 1):2255-9. doi: 10.1097/01.ju.0000127733.01845.57. J Urol. 2004. PMID: 15126797

3

CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.

Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R. Zhao H, et al. Among authors: greene kl. Cancer. 2005 Jul 1;104(1):44-52. doi: 10.1002/cncr.21135. Cancer. 2005. PMID: 15895377 Free article.

4

Who is the average patient presenting with prostate cancer?

Greene KL, Cowan JE, Cooperberg MR, Meng MV, DuChane J, Carroll PR; Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Investigators. Greene KL, et al. Urology. 2005 Nov;66(5 Suppl):76-82. doi: 10.1016/j.urology.2005.06.082. Urology. 2005. PMID: 16194711 Free article.

5

Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE.

Greene KL, Elkin EP, Karapetian A, Duchane J, Carroll PR, Kane CJ; CaPSURE Investigators. Greene KL, et al. J Urol. 2006 Jan;175(1):125-9; discussion 129. doi: 10.1016/S0022-5347(05)00056-X. J Urol. 2006. PMID: 16406887

6

Prostate specific antigen best practice statement: 2009 update.

Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Greene KL, et al. J Urol. 2009 Nov;182(5):2232-41. doi: 10.1016/j.juro.2009.07.093. Epub 2009 Sep 24. J Urol. 2009. PMID: 19781717

7

Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.

Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll PR, Chan JM. Tasian GE, et al. Among authors: greene kl. Urol Oncol. 2012 Mar-Apr;30(2):155-60. doi: 10.1016/j.urolonc.2009.12.019. Epub 2010 Aug 25. Urol Oncol. 2012. PMID: 20800514

8

Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.

Dall'Era MA, Cowan JE, Simko J, Shinohara K, Davies B, Konety BR, Meng MV, Perez N, Greene K, Carroll PR. Dall'Era MA, et al. BJU Int. 2011 Apr;107(8):1232-7. doi: 10.1111/j.1464-410X.2010.09589.x. BJU Int. 2011. PMID: 20804478

9

Outcomes of active surveillance for men with intermediate-risk prostate cancer.

Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR. Cooperberg MR, et al. Among authors: greene kl. J Clin Oncol. 2011 Jan 10;29(2):228-34. doi: 10.1200/JCO.2010.31.4252. Epub 2010 Nov 29. J Clin Oncol. 2011. PMID: 21115873 Free PMC article.

10

Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.

Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll PR, Satariano W. Sadetsky N, et al. Cancer. 2011 Oct 1;117(19):4406-13. doi: 10.1002/cncr.26064. Epub 2011 Mar 15. Cancer. 2011. PMID: 21412760 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page